Company: ANTX
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0000950170-25-044366
Chunk: 38

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 16
Chunk 38
---
None.

90

Exhibit Index

    Incorporated by Reference

    ExhibitNumber
     
    Description
     
    Form
     
    File No.
     
    Exhibit
     
    Filing Date

    3.1
     
    ﻿Amended and Restated Certificate of Incorporation.
     
    8-K
     
    001-41331
     
    3.1
     
    June 24 2025

    3.2
     
    ﻿Amended and Restated Bylaws.
     
    S-1
     
    333-263295
     
    3.4
     
    March 4, 2022

    3.3
     
    Certificate of Designations of Series A Junior Participating Preferred Stock of AN2 Therapeutics, Inc. filed with the Secretary of State of the State of Delaware on August 15, 2024.
     
    8-K
     
    001-41331
     
    3.1
     
    August 19, 2024

    4.1
     
    Form of Common Stock Certificate.
     
    S-1
     
    333-263295
     
    4.1
     
    March 21, 2022

    4.2
     
    Amended and Restated Investors’ Rights Agreement, by and among the Registrant and certain of its stockholders, dated March 5, 2021.
     
    S-1
     
    333-263295
     
    4.2
     
    March 4, 2022

    4.3
     
    Description of Securities
     
    10-K
     
    001-41331
     
    4.3
     
    March 29, 2023

    4.4
     
    Rights Agreement, dated as of August 15, 2024, between AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC, which includes Form of Certificate of Designations of Series A Junior Participating Preferred Stock as Exhibit A, the Form of Rights Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Stock as Exhibit C.
     
    8-K
     
    001-41331
     
    4.1
     
    August 19, 2024

    10.1#
     
    AN2 Therapeutics